Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opiranserin PCA versus fentanyl PCA after laparoscopic or robotic hysterectomy
KCT0012290Phase 4Recruiting
- Sponsor
- Samsung Medical Center
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of opiranserin, fentanyl in postoperative pain, sponsored by Samsung Medical Center. Started Aug 2026; status: recruiting.
02
Drugs
opiranserinfentanyl
03
Conditions
postoperative pain
Beyond the preview
Go deeper on KCT0012290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0012290.